Dashboard

Legend Biotech Corporation

LEGNNASDAQ

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$4.3B

Price$22.2252w $16.65 – $44.32

Conviction3/ 5

Revenue (TTM)$1.1B

Revenue growth YoY+56.4%

P/E (trailing)—

Gross margin55.0%

Operating margin-11.9%

Net margin-22.0%

52w price change-24.2%

Next earningsAug 10, 2026

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

Jul 15
OtherSEC
Legend Biotech filed Form 6-K with SEC on 2026-07-15 (items unspecified).
Jul 2
Ownership changeSEC
Form 4 insider transaction filing for LEGN
Jul 2
Ownership changeSEC
SEC Form 4 insider transaction filing
Jun 29
Ownership changeSEC
SEC Form 4 insider transaction filing.
Jun 22
OtherSEC
Legend Biotech filed Form 6-K as foreign private issuer report.
Jun 18
Securities offeringSEC
Filed SEC Form 424B5 prospectus supplement.
Jun 17
Securities offeringSEC
Filed 424B5 prospectus supplement related to securities offering.
Jun 15
OtherSEC
Legend Biotech filed Form 6-K with the SEC.
Jun 2
OtherSEC
Legend Biotech filed Form 6-K with the SEC on 2026-06-02.
Jun 1
OtherSEC
Legend Biotech Corporation filed Form 6-K with the SEC.
May 21
OtherSEC
Legend Biotech filed Form 6-K foreign issuer report.
May 12
Financial resultsSEC
Legend Biotech files 6-K report for quarter ended March 31, 2026.

Not financial advice — research and opinion only. Disclosures